Merck's Hedera Adoption Boosts HBAR Price Prediction
Pharmaceutical company Merck has integrated its M-Trust product-authentication technology with TrackTrace, a digital product passport platform built on the Hedera network. This adoption adds another major enterprise use case for Hedera at a time when HBAR is trading around $0.075.
A sustained recovery could bring $0.08 into focus first before buyers challenge $0.09, which would extend the token's recovery and reinforce the network's reputation for enterprise-focused blockchain infrastructure.
DigiTap, another project with a presale price of $0.0589, is also eyeing a move to $1, representing approximately 17x from today's presale price. The project has already raised over $11.72 million and its beta app is downloadable through the App Store and Google Play.